Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
about
Fast disintegrating tablets: Opportunity in drug delivery systemPreparation and characterization of solid dispersions of carvedilol with PVP K30Development and evaluation of fixed dose bi therapy sublingual tablets for treatment stress hypertension and anxietyChallenges and emerging solutions in the development of compressed orally disintegrating tablets.Evaluation of tadalafil nanosuspensions and their PEG solid dispersion matrices for enhancing its dissolution properties.A pharmaceutical study on chlorzoxazone orodispersible tablets: formulation, in-vitro and in-vivo evaluation.Formulation and optimization of orodispersible tablets of diazepam.Optimization of fast dissolving etoricoxib tablets prepared by sublimation technique.Freeze Dried Quetiapine-Nicotinamide Binary Solid Dispersions: A New Strategy for Improving Physicochemical Properties and Ex Vivo Diffusion.Design and evaluation of taste masked dextromethorphan hydrobromide oral disintegrating tablets.Perphenazine solid dispersions for orally fast-disintegrating tablets: physical stability and formulation.Novel taste-masked orally disintegrating tablets for a highly soluble drug with an extremely bitter taste: design rationale and evaluation.Enhancement of solubility, dissolution release profile and reduction in ulcerogenicity of piroxicam by inclusion complex with skimmed milk.Enhanced oral bioavailability of isradipine via proniosomal systems.Rapidly absorbed orodispersible tablet containing molecularly dispersed felodipine for management of hypertensive crisis: development, optimization and in vitro/in vivo studies.Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.Phenylalanine-free taste-masked orodispersible tablets of fexofenadine hydrochloride: development, in vitro evaluation and in vivo estimation of the drug pharmacokinetics in healthy human volunteers.QbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersion.The Impact of Amorphisation and Spheronization Techniques on the Improved in Vitro & in Vivo Performance of Glimepiride Tablets.A pilot human pharmacokinetic study and influence of formulation factors on orodispersible tablet incorporating meloxicam solid dispersion using factorial design.The role of SeDeM for characterizing the active substance and polyvinyilpyrrolidone eliminating metastable forms in an oral lyophilizate-A preformulation study.
P2860
Q24612643-75C8F61E-B3F9-4656-8B82-50B2EE02DBE5Q34976552-C7862603-D32E-4E33-8EE3-5AACBDD363A9Q37186583-85F0C543-0775-497B-AA20-BDADB65508E4Q38232117-F019C488-F1AE-482C-A59A-521996B0E3ACQ38554933-758DD54E-F7EB-4D81-9E33-A6D8FE618D71Q39177332-8ADDD992-BA2A-4A82-8128-9E4DA1EAA5F2Q39923380-B741ABE1-3126-4814-BEFA-D07FF3760C49Q39963047-3B940718-37BA-4E54-9546-57AD9C968757Q42353210-7580A32C-73BA-444E-B8D8-C8A96ACF6C10Q42785253-300104AD-DAA4-49B8-8B61-2E1F4B4DCE01Q43232050-32D07576-FF43-41EA-9850-B27168901554Q43957526-44E34305-1DDC-4C55-B2AD-589E4B256994Q44027802-70B98A49-2CD8-4B22-8026-27852741C5E7Q45129183-7945080D-75FC-475F-A25A-F8396E9CAD34Q45259769-D1F1049D-5BD3-4469-AEED-05A95CA6D15FQ46418404-800D2DFC-FC27-4F1C-9118-60491F89766BQ46498557-5446E758-77CE-46B3-9F68-69A1244581F4Q46671481-2D91B329-0EB1-4582-9AE1-B380983F504EQ49265974-231A603E-374F-4617-9E7B-09273F5A46F5Q51689376-F27DA29C-A27A-4F11-8E6A-C2B5D08D576BQ53403186-08759ADA-DA13-4BAF-9DC9-2B664A737567
P2860
Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Formulation and optimization o ...... ng rofecoxib solid dispersion.
@en
type
label
Formulation and optimization o ...... ng rofecoxib solid dispersion.
@en
prefLabel
Formulation and optimization o ...... ng rofecoxib solid dispersion.
@en
P2093
P2860
P356
P1433
P1476
Formulation and optimization o ...... ng rofecoxib solid dispersion.
@en
P2093
Ahmed S Zidan
Mohammed A Hammad
Nagia A Megrab
Omaima A Sammour
P2860
P2888
P356
10.1208/PT070255
P407
P577
2006-06-16T00:00:00Z
P5875
P6179
1039214487